replicator < reply < repolarization

Facettes :

List of bibliographic references indexed by reply

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]

Ident.	Authors (with country if any)	Title
000183 (2016)	Daniel Weintraub [États-Unis] ; Helen C. Kales ; Connie Marras [Canada]	The Danger of Not Treating Parkinson Disease Psychosis-Reply.
000211 (2016)	Christine Klein [Allemagne] ; Anthony Lang [Canada] ; Bart P. Van De Warrenburg [Pays-Bas] ; Carolyn M. Sue [Australie] ; Sarah J. Tabrizi [Royaume-Uni] ; Lars Bertram [Allemagne] ; Saadet Mercimek-Mahmutoglu [Canada] ; Darius Ebrahimi-Fakhari [Allemagne] ; Thomas T. Warner [Royaume-Uni] ; Alexandra Durr [France] ; Birgit Assmann [Allemagne] ; Vladimir Kostic [Serbie] ; Katja Lohmann [Allemagne] ; Connie Marras [Canada]	Reply letter to Jinnah "Locus pocus" and Albanese "Complex dystonia is not a category in the new 2013 consensus classification": Necessary evolution, no magic!
000548 (2015)	Camila C. Aquino [Canada] ; Anthony E. Lang [Canada]	Restless genital syndrome--in reply.
000942 (2014)	Alfonso Fasano [Canada] ; Andres M. Lozano	Reply: the FM/AM world is shaping the future of deep brain stimulation.
000943 (2014)	Oury Monchi [Canada] ; Alexandru Hanganu [Canada]	Reply: Is nucleus accumbens atrophy correlated with cognitive symptoms of Parkinson’s disease?
000944 (2014)	Madison T. Gray [Canada] ; Douglas A. Gray ; John M. Woulfe	Reply to: alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
000945 (2014)	Naomi P. Visanji [Canada] ; Connie Marras ; Louis W C. Liu ; Lili-Naz Hazrati ; Anthony E. Lang	Reply to: Gray et al.
000F41 (2013)	Mark J. Edwards [Royaume-Uni] ; Mark J. Lang [Canada] ; Mark J. Bhatia [Royaume-Uni]	Reply to Drs. Kurlan, Fasano, and Evans: A clinically useful definition of stereotypies
001279 (2012)	Connie Marras [Canada] ; David Oakes [États-Unis]	Author reply to Holford, Vu and Nutt regarding ‘piecing together the puzzle of progression and mortality in Parkinson's disease’
001371 (2012)	Samuel M. Goldman [États-Unis] ; Patricia J. Quinlan [États-Unis] ; G. Webster Ross [États-Unis] ; Connie Marras [Canada] ; J. William Langston [États-Unis] ; Caroline M. Tanner [États-Unis]	Reply
001799 (2011)	Cory Toth [Canada] ; Douglas Zochodne [Canada] ; Oksana Suchowersky [Canada]	Reply
001800 (2011)	Kimberly A. Mcdowell [États-Unis] ; Wei-Bin Shen ; Aubrey A. Siebert [États-Unis] ; Sarah M. Clark ; H. A. Jinnah [États-Unis] ; Carole Sztalryd ; Paul S. Fishman [États-Unis] ; Christopher A. Shaw [Canada] ; M. Samir Jafri [États-Unis] ; Paul J. Yarowsky [États-Unis]	Reply
001801 (2011)	I. In Yeh [Canada] ; Eric W. Tsang [Canada] ; Clement Hamani [Canada] ; Elena Moro [Canada] ; Filomena Mazzella [Canada] ; Yu-Yan Poon [Canada] ; Andres M. Lozano [Canada] ; Robert Chen [Canada]	Reply: Where are the somatosensory evoked potentials recorded from DBS leads implanted in the human pedunculopontine tegmental nucleus generated?
001802 (2011)	Alberto J. Espay [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Connie Marras [Canada] ; Rob Fowler [Canada] ; Mark H. Eckman [États-Unis]	Reply: Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: Need for long‐term clinical trials
001B07 (2010)	Cory Toth [Canada] ; Oksana Suchowersky [Canada] ; Douglas Zochodne [Canada]	Reply: Neuropathy as a potential complication of levodopa use in Parkinson's disease: A pharmacological and pharmacovigilance point of view
001B79 (2010)	Cory Toth [Canada] ; Douglas Zochodne [Canada] ; Oksana Suchowersky [Canada]	Reply
001B80 (2010)	Cory Toth [Canada] ; Douglas Zochodne [Canada] ; Oksana Suchowersky [Canada]	Reply
001B81 (2010)	Omar Khan [États-Unis] ; Massimo Filippi [Italie] ; Mark S. Freedman [Canada] ; Frederik Barkhof [Pays-Bas] ; Paula Dore-Duffy [États-Unis] ; Hans Lassman [Autriche] ; Bruce Trapp [États-Unis] ; Amit Bar-Or [Canada] ; Imad Zak [États-Unis] ; Marilyn J Siegel [États-Unis] ; Robert Lisak [États-Unis]	Reply
001B82 (2010)	Jeffrey L. Bennett [États-Unis] ; Gregory P. Owens [États-Unis] ; Don Gilden [États-Unis] ; Jack P. Antel [Canada] ; Bernard Hemmer [Allemagne]	Reply
001B83 (2010)	Michael S. Okun [États-Unis] ; Anthony Lang [Canada] ; Joseph Jankovic [États-Unis]	Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease
002280 (2008)	Edor Kabashi [Canada] ; Paul N. Valdmanis [Canada] ; Patrick Dion [Canada] ; Guy A. Rouleau [Canada]	Reply

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "reply" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "reply" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    reply
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022